b Tested in sodium chloride 0.9%.
c Tested in sterile water for injection.
d Tested in bacteriostatic sodium chloride 0.9% preserved with benzyl alcohol 0.9%.
e Tested in dextrose 5% with potassium chloride 0.02 mM/mL.
f Lyophilized formulation tested.
g Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.
h Test performed using the formulation WITHOUT edetate disodium.
i Tested in Ringer’s injection, lactated.
j Injected via Y-site into an administration set running azithromycin.
k Tested with albumin human 0.1%.
l Ampicillin component. Ampicillin in a 2:1 fixed-ratio concentration with sulbactam.
m Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.
n Not specified whether concentration refers to single component or combined components.
o Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.
p Tested in both dextrose 5% and sodium chloride 0.9%.
q Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.
s Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.
t Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.
u Subvisible particulate test methods include light obscuration, flow imaging microscopy, and backgrounded membrane imaging.